John E. Ray
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 14
- Antifungal resistance and susceptibility 11
- HIV/AIDS Research and Interventions 8
- Virology top 5%
- HIV Research and Treatment 13
- Transplantation top 5%
- Oncology top 5%
- Colorectal Cancer Surgical Treatments 7
- Epidemiology top 2%
-
- Diverticular Disease and Complications 9
- Gastrointestinal disorders and treatments 8
-
- Antibiotics Pharmacokinetics and Efficacy 8
- Co-authors
- Andrew J. McLachlanAlan E. TimmckeMichael DoltonRichard O. DayByron J. GathrightDeborah MarriottJohn C. WeedGarry G. Graham
- Journals
- Diseases of the Colon & Rectum (26 papers)Therapeutic Drug Monitoring (8 papers)Antimicrobial Agents and Chemotherapy (6 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
John E. Ray
90 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Infectious Diseases 1.1k
- Virology 218
- Transplantation 101
- Oncology 917
- Epidemiology 995
Countries citing papers authored by John E. Ray
This map shows the geographic impact of John E. Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Ray more than expected).
Fields of papers citing papers by John E. Ray
This network shows the impact of papers produced by John E. Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Ray. The network helps show where John E. Ray may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John E. Ray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 33 | |
| 2 | 2010 | 31 | |
| 3 | 2010 | 14 | |
| 4 | 2009 | 131 | |
| 5 | 2009 | 10 | |
| 6 | 2006 | 114 | |
| 7 | 2006 | 22 | |
| 8 | 2006 | 50 | |
| 9 | 2005 | 28 | |
| 10 | 2005 | 46 | |
| 11 | 2005 | 42 | |
| 12 | 2005 | 68 | |
| 13 | 2003 | 20 | |
| 14 | 2003 | 55 | |
| 15 | 2002 | 26 | |
| 16 | 2002 | 20 | |
| 17 | 1994 | 35 | |
| 18 | 1993 | 157 | |
| 19 | 1990 | 34 | |
| 20 | 1989 | 51 |
About John E. Ray
John E. Ray is a scholar working on Virology, Transplantation, Infectious Diseases, Toxicology and Gastroenterology, having authored 92 papers that have together received 4.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (13 papers), Antifungal resistance and susceptibility (11 papers), Diverticular Disease and Complications (9 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Gastrointestinal disorders and treatments (8 papers), HIV/AIDS Research and Interventions (8 papers) and Colorectal Cancer Surgical Treatments (7 papers). The work is most often cited by research in Infectious Diseases (1.1k citations), Virology (218 citations), Transplantation (101 citations), Oncology (917 citations) and Epidemiology (995 citations). John E. Ray has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Andrew J. McLachlan, Alan E. Timmcke, Michael Dolton, Richard O. Day, Byron J. Gathright, Deborah Marriott, John C. Weed, Garry G. Graham, Kenneth M. Williams and Carl M. J. Kirkpatrick. Their work appears in journals such as Diseases of the Colon & Rectum, Therapeutic Drug Monitoring, Antimicrobial Agents and Chemotherapy, Journal of NeuroVirology and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.